168 related articles for article (PubMed ID: 18855244)
1. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period.
Lile JA; Stoops WW; Hays LR; Rush CR
Am J Drug Alcohol Abuse; 2008; 34(6):721-9. PubMed ID: 18855244
[TBL] [Abstract][Full Text] [Related]
2. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.
Stoops WW; Lile JA; Lofwall MR; Rush CR
Am J Drug Alcohol Abuse; 2007; 33(6):769-76. PubMed ID: 17994473
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole maintenance increases smoked cocaine self-administration in humans.
Haney M; Rubin E; Foltin RW
Psychopharmacology (Berl); 2011 Aug; 216(3):379-87. PubMed ID: 21373790
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.
Stoops WW; Blackburn JW; Hudson DA; Hays LR; Rush CR
Drug Alcohol Depend; 2008 Jan; 92(1-3):282-5. PubMed ID: 17719727
[TBL] [Abstract][Full Text] [Related]
5. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.
Stoops WW; Bennett JA; Lile JA; Sevak RJ; Rush CR
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():111-7. PubMed ID: 23994622
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.
Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
J Psychopharmacol; 2011 Nov; 25(11):1469-79. PubMed ID: 20952456
[TBL] [Abstract][Full Text] [Related]
7. An open-label study of aripiprazole in nonschizophrenic crack-dependent patients.
Vorspan F; Bellais L; Keijzer L; Lépine JP
J Clin Psychopharmacol; 2008 Oct; 28(5):570-2. PubMed ID: 18794657
[No Abstract] [Full Text] [Related]
8. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
Kane JM; Sanchez R; Perry PP; Jin N; Johnson BR; Forbes RA; McQuade RD; Carson WH; Fleischhacker WW
J Clin Psychiatry; 2012 May; 73(5):617-24. PubMed ID: 22697189
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
[TBL] [Abstract][Full Text] [Related]
10. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
Stoops WW; Lile JA; Glaser PE; Rush CR
Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
[TBL] [Abstract][Full Text] [Related]
11. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
Rush CR; Stoops WW; Hays LR
Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study.
Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
Am J Addict; 2011; 20(2):179-80. PubMed ID: 21314764
[No Abstract] [Full Text] [Related]
13. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study.
Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
Curr Pharm Des; 2011; 17(14):1376-83. PubMed ID: 21524261
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
McEvoy JP; Daniel DG; Carson WH; McQuade RD; Marcus RN
J Psychiatr Res; 2007 Dec; 41(11):895-905. PubMed ID: 17631314
[TBL] [Abstract][Full Text] [Related]
18. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
